Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
| Particulars | Details |
|---|---|
| Title |
Cefpodoxime 50 Mg Clavulanic Acid 31.25 Mg Suspn. In Bottle, At Least 30ml Phial
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106597320 |
|
Reference Number |
IG255172 |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | Kolkata |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/022025/106597320/viewNitPdf_4854375.pdf |
| Start Date | February 03, 2025 18:48 |
| End Date |
Expired
10/02/2025
Expired 557 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Syp. cefpodoxime proxetil 50mg/ 5ml in 30ml phial
For complete deion and other details, please refer to tender
Read moreSyp. cefpodoxime proxetil 50mg/5ml dry syrup 30ml bottle
For complete deion and other details, please refer to tender
Read moreSyp. cefpodoxime clavulanic acid, 50mg31.5mg in 30ml bottle (item no. 1087 of ami 2024-25)
For complete deion and other details, please refer to tender
Read moreAmoxycillin 200mg. with clavulanic acid 28.5mg. per 5ml. suspension 30ml. phial
For complete deion and other details, please refer to tender
Read moreSyp. cefpodoxime proxetil 100mg/ 5ml in 30ml phial
For complete deion and other details, please refer to tender
Read moreCefpodoxime 200mg clavulanic acid 125mg
For complete deion and other details, please refer to tender
Read moreSyp. cefpodoxime 50mg/05ml, 30ml bottle (item no. 1062 of ami 2024-25)
For complete deion and other details, please refer to tender
Read moreSyp. cefpodoxime 50mg/05ml, 30ml bottle (item no. 1062 of ami 2024-25)
For complete deion and other details, please refer to tender
Read moreSyp. cefixime 50mg/ 5ml 30ml phial.
For complete deion and other details, please refer to tender
Read moreof your Industry type